These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6682405)

  • 1. Loss of surface fibronectin from human lung fibroblasts exposed to cytotoxin from Clostridium difficile.
    Ahlgren T; Florin I; Jarstrand C; Thelestam M
    Infect Immun; 1983 Mar; 39(3):1470-2. PubMed ID: 6682405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morphological changes in human embryonic lung fibroblasts caused by cytotoxins of various Clostridium species].
    Schallehn G; Wolff MH
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Jan; 267(3):367-78. PubMed ID: 3376617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the cytotoxin of Clostridium difficile on cultured hepatoma cells.
    Rihn B; Beck G; Monteil H; Lecerf F; Girardot R
    Biol Cell; 1985; 53(1):23-32. PubMed ID: 2581643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A.
    Torres JF
    J Med Microbiol; 1991 Jul; 35(1):40-4. PubMed ID: 1906544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of age on the sensitivity of cell cultures to Clostridium difficile toxin.
    Tichota-Lee J; Jaqua-Stewart MJ; Benfield D; Simmons JL; Jaqua RA
    Diagn Microbiol Infect Dis; 1987 Dec; 8(4):203-14. PubMed ID: 3449315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADP-ribosylation in Clostridium difficile toxin-treated cells is not related to cytopathogenicity of toxin B.
    Florin I; Thelestam M
    Biochim Biophys Acta; 1991 Jan; 1091(1):51-4. PubMed ID: 1995067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity.
    Vesely DL; Straub KD; Nolan CM; Rolfe RD; Finegold SM; Monson TP
    Infect Immun; 1981 Jul; 33(1):285-91. PubMed ID: 6114928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of cellular phospholipase A2 by Clostridium difficile toxin B.
    Shoshan MC; Florin I; Thelestam M
    J Cell Biochem; 1993 May; 52(1):116-24. PubMed ID: 8320270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intoxication of cultured human lung fibroblasts with Clostridium difficile toxin.
    Florin I; Thelestam M
    Infect Immun; 1981 Jul; 33(1):67-74. PubMed ID: 6167521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microfilament-disrupting Clostridium difficile toxin B causes multinucleation of transformed cells but does not block capping of membrane Ig.
    Shoshan MC; Aman P; Skog S; Florin I; Thelestam M
    Eur J Cell Biol; 1990 Dec; 53(2):357-63. PubMed ID: 2081549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile toxin.
    Chang TW; Bartlett JG; Taylor NS
    Pharmacol Ther; 1981; 13(3):441-52. PubMed ID: 7280010
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperphosphorylation of calnexin, a chaperone protein, induced by Clostridium difficile cytotoxin.
    Schué V; Green GA; Girardot R; Monteil H
    Biochem Biophys Res Commun; 1994 Aug; 203(1):22-8. PubMed ID: 8074658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of cellular proteins in response to treatment with Clostridium difficile toxin B and Clostridium sordellii toxin L.
    Ciesielski-Treska J; Ulrich G; Baldacini O; Monteil H; Aunis D
    Eur J Cell Biol; 1991 Oct; 56(1):68-78. PubMed ID: 1724754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internalization of Clostridium difficile cytotoxin into cultured human lung fibroblasts.
    Florin I; Thelestam M
    Biochim Biophys Acta; 1983 Dec; 763(4):383-92. PubMed ID: 6652117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of Clostridium difficile toxins on tissue-cultured cells.
    Donta ST; Sullivan N; Wilkins TD
    J Clin Microbiol; 1982 Jun; 15(6):1157-8. PubMed ID: 7107845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative cell-adhesion assay for Clostridium difficile cytotoxin.
    Mayall BC; Edmonds C; Griffin GE
    J Med Microbiol; 1987 Nov; 24(3):197-203. PubMed ID: 3669053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between cytotoxin production and sporulation in Clostridium difficile.
    Kamiya S; Ogura H; Meng XQ; Nakamura S
    J Med Microbiol; 1992 Sep; 37(3):206-10. PubMed ID: 1518037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial cytotoxins.
    Chaves-Olarte E; Löw P; Freer E; Norlin T; Weidmann M; von Eichel-Streiber C; Thelestam M
    J Biol Chem; 1999 Apr; 274(16):11046-52. PubMed ID: 10196187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assay of cytopathogenic toxins in cultured cells.
    Thelestam M; Florin I
    Methods Enzymol; 1994; 235():679-90. PubMed ID: 8057936
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study of immunological properties and cytotoxic effects of Clostridium difficile toxin B and Clostridium sordellii toxin L.
    Baldacini O; Girardot R; Green GA; Rihn B; Monteil H
    Toxicon; 1992 Feb; 30(2):129-40. PubMed ID: 1557784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.